Grove Bank & Trust’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11K Sell
10
-3
-23% -$643 ﹤0.01% 797
2026
Q1
$2.88K Hold
13
﹤0.01% 761
2025
Q4
$3.3K Buy
13
+3
+30% +$753 ﹤0.01% 765
2025
Q3
$2.47K Sell
10
-60
-86% -$14.4K ﹤0.01% 767
2025
Q2
$16.8K Sell
70
-75
-52% -$17.5K ﹤0.01% 553
2025
Q1
$32.9K Buy
145
+142
+4,733% +$31.2K ﹤0.01% 457
2024
Q4
$617 Hold
3
﹤0.01% 734
2024
Q3
$728 Buy
+3
New +$702 ﹤0.01% 713
2024
Q1
Sell
-51
Closed -$11.2K 600
2023
Q4
$11.2K Hold
51
﹤0.01% 480
2023
Q3
$11.2K Buy
+51
New +$11.5K ﹤0.01% 509
2023
Q1
Sell
-279
Closed -$52K 747
2022
Q4
$52K Buy
+279
New +$49.1K 0.01% 365

Other funds holding STE

Grove Bank & Trust's STE Position: Q2 2026 in Review

Grove Bank & Trust reduced its Steris (STE) stake by 23% in Q2 2026, selling an estimated $643 and leaving 10 shares worth $2.11K. The position accounts for ﹤0.01% of the portfolio, ranked #797.

Grove Bank & Trust first reported a position in STE in Q4 2022 and has held it in 11 quarters since. The position peaked at $52K in Q4 2022. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Grove Bank & Trust held 10 shares of Steris worth $2.11K as of Q2 2026.
  • Grove Bank & Trust sold 3 Steris shares in Q2 2026, an estimated $643.
  • Steris made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #797 holding.
  • Grove Bank & Trust first reported a position in Steris in Q4 2022 and has held it in 11 quarters since.
  • Grove Bank & Trust's Steris position peaked at $52K in Q4 2022.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.